Clinical trials
Terminated Kidney Failure, Chronic trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vantive Health LLC | 3 |
| C. R. Bard | 2 |
| Johns Hopkins University | 2 |
| University of Pennsylvania | 2 |
| W.L.Gore & Associates | 2 |
| Aethlon Medical Inc. | 1 |
| Angiotech Pharmaceuticals | 1 |
| Assaf-Harofeh Medical Center | 1 |
| Association Pour L'utilisation Rein Artificiel Région Lyonnaise | 1 |
| Centre Hospitalier Departemental Vendee | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Failure, Chronic | 53 |
| Renal Insufficiency, Chronic | 7 |
| Renal Insufficiency | 4 |
| Acute Kidney Injury | 3 |
| Arteriovenous Fistula | 3 |
| Hypertension | 2 |
| Albuminuria | 1 |
| Anemia | 1 |
| Cardio-Renal Syndrome | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.